MARKET

TTOO

TTOO

T2 Biosystems
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.140
+0.020
+1.79%
After Hours: 1.170 +0.03 +2.63% 19:59 05/18 EDT
OPEN
1.120
PREV CLOSE
1.120
HIGH
1.170
LOW
1.100
VOLUME
1.92M
TURNOVER
--
52 WEEK HIGH
3.790
52 WEEK LOW
0.5750
MARKET CAP
171.12M
P/E (TTM)
-3.7525
1D
5D
1M
3M
1Y
5Y
T2 Biosystems shares rise as Q1 top-line up 173%
T2 Biosystems announces financial results for the first quarter ended March 31, 2021.The company achieved Q1 revenue of $7M, including product revenue of $4.7M, representing growth of 173% and 345%,
Seekingalpha · 05/07 13:15
Thinking about buying stock in iBio, T2 Biosystems, Viewray, GoPro, or Tilray?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IBIO, TTOO, VRAY, GPRO, and TLRY.
PR Newswire - PRF · 05/07 12:30
TLRY, ET, ROKU and NET among premarket gainers
iBio (IBIO) +33% on COVID-19 study update.Orgenesis (ORGS) +11% on Q1 results.Chemomab Therapeutics (CMMB) +12%.T2 Biosystems, Inc. (TTOO) +11% on Q1 results.ViewRay (VRAY) +12%.Epizyme (EPZM) +11% on Q1 results.CureVac N.V. (CVAC) +9%.Roku (ROKU) +9% on
Seekingalpha · 05/07 12:25
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Benzinga · 05/07 12:16
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6)
Benzinga · 05/07 11:40
32 Stocks Moving in Friday's Pre-Market Session
Gainers Assertio Holdings, Inc. (NASDAQ: ASRT) shares rose 44.2% to $0.7190 in pre-market trading after the company reported better-than-expected Q1 results.
Benzinga · 05/07 11:00
T2 Biosystems (TTOO) Reports Q1 Loss, Tops Revenue Estimates
T2 Biosystems (TTOO) delivered earnings and revenue surprises of 0.00% and 1.11%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/07 01:29
15 Stocks Moving In Thursday's After-Hours Session
Gainers Expedia Group (NASDAQ: EXPE) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.
Benzinga · 05/06 23:04
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TTOO. Analyze the recent business situations of T2 Biosystems through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TTOO stock price target is 2.750 with a high estimate of 3.500 and a low estimate of 1.250.
EPS
Institutional Holdings
Institutions: 127
Institutional Holdings: 33.01M
% Owned: 22.23%
Shares Outstanding: 150.11M
TypeInstitutionsShares
Increased
22
5.01M
New
25
1.94M
Decreased
17
1.62M
Sold Out
10
459.17K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.31%
Healthcare Equipment & Supplies
+0.35%
Key Executives
Non-Executive Chairman
John McDonough
President/Chief Executive Officer/Director
John Sperzel
Chief Financial Officer
John Sprague
Chief Operating Officer
Alec Barclay
Chief Scientific Officer
Thomas Lowery
Vice President/General Counsel
Michael Gibbs
Other
Aparna Ahuja
Other
Anthony Pare
Lead Director/Independent Director
John Cumming
Director
Seymour Liebman
Independent Director
Thierry Bernard
Independent Director
David Elsbree
Independent Director
Ninfa Saunders
Independent Director
Stan Lapidus
Independent Director
Robin Toft
No Data
About TTOO
T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.

Webull offers kinds of T2 Biosystems Inc stock information, including NASDAQ:TTOO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TTOO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TTOO stock methods without spending real money on the virtual paper trading platform.